Stay updated on Fremanezumab in Preventing Chronic Migraine Clinical Trial
Sign up to get notified when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.

Latest updates to the Fremanezumab in Preventing Chronic Migraine Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded revision v3.4.2. Removed the funding-status notice and the earlier revision v3.4.1.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding status and updated the page revision to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedUI updates include showing the glossary option, color‑coding explanations (green for additions, red for deletions), and revision notes updating from v3.3.4 to v3.4.0.SummaryDifference0.4%

- Check42 days agoChange DetectedThe history now includes a new Revision: v3.3.4 and removes Revision: v3.3.3, reflecting a minor administrative update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedResults Posted including Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and updated Study Status (Revision: v3.3.3, 2025-12-19). Previous entry 'Results Submitted' and 'HHS Vulnerability Disclosure' removed (Revision: v3.3.2, 2025-10-28).SummaryDifference0.5%

- Check92 days agoChange DetectedThe Record History now shows revision v3.3.2 with a Returned date of 2025-11-21 and a QC status of Not Concluded. New sections such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and other document sections were added, and the Study Status was updated.SummaryDifference0.5%

Stay in the know with updates to Fremanezumab in Preventing Chronic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.